Stephens Kristin
Insider CIK 1865490 · SYRS Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-11-18 | 2024-11-20 | 36,133 | $0.22 | $7.9K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-10-31 | 2024-11-04 | 17,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-10-31 | 2024-11-04 | 17,000 | — | $0 | 42,237 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-10-31 | 2024-11-04 | 6,104 | $2.09 | $12.8K | 36,133 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-04-01 | 2024-04-02 | 4,218 | $5.12 | $21.6K | 25,237 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-31 | 2024-04-02 | 11,666 | — | $0 | 23,334 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 4,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-31 | 2024-04-02 | 11,666 | — | $0 | 29,455 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 17,789 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-11-01 | 2023-11-02 | 5,676 | $2.22 | $12.6K | 15,789 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-10-31 | 2023-11-02 | 17,000 | — | $0 | 17,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-10-31 | 2023-11-02 | 17,000 | — | $0 | 21,465 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-04-03 | 2023-04-04 | 623 | $2.58 | $1.6K | 4,465 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 5,088 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-02-16 | 2023-02-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 44,500 | — | $0 | 44,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 34,000 | — | $0 | 34,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2022-04-01 | 2022-04-04 | 14,115 | $1.12 | $15.8K | 30,885 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |